The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations, and Treatment

S Louw1,2, B F Jacobson3,4, E S Mayne4,5

  • 1Department of Molecular Medicine and Haematology, National Health Laboratory Service, Johannesburg, South Africa. Susan.louw@nls.ac.za.

Insights

The COVID-19 pandemic causes significant abnormal thrombosis, affecting both large and small blood vessels. Further research is needed to understand the virus

Area of Science:

  • Virology
  • Pathophysiology
  • Hematology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, shares similarities with the previous SARS epidemic due to their shared coronavirus origin.
  • A key differentiator of COVID-19 is the significant morbidity and mortality associated with abnormal thrombosis.
  • This thrombotic phenomenon impacts both macrovascular and microvascular levels, presenting uniquely in this disease.

Purpose of the Study:

  • To highlight the unique thrombotic complications of COVID-19.
  • To discuss the presence of SARS-CoV-2 in pulmonary endothelium and its link to respiratory issues.
  • To address the elevated D-dimer levels observed in COVID-19 patients.

Main Methods:

  • Review of existing literature on COVID-19 pathophysiology.
  • Analysis of clinical observations regarding thrombosis in COVID-19.
  • Examination of viral presence in affected tissues.

Main Results:

  • COVID-19 is characterized by unique macro- and microvascular thrombosis.
  • SARS-CoV-2 has been identified in the endothelium of pulmonary alveoli, contributing to respiratory distress.
  • Elevated D-dimer concentrations are a frequent finding in COVID-19 patients.

Conclusions:

  • Abnormal thrombosis is a major contributor to COVID-19 severity.
  • The precise pathophysiological mechanisms of COVID-19 require further elucidation.
  • Optimal anticoagulation strategies for COVID-19 are yet to be established.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
106
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.7K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
92